European Markets for Orthopedic Biomaterials
The European orthopedic biomaterials market is expected to reach €376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment.
The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantation (ACI). As the market continued to recover from the economic crisis, slow growth was often seen across different regions. The ACI market underwent drastic changes in 2012 due to modifications in the European Medicines Agency (EMA) regulations.
While autografts were still commonly used in 2012, easy accessibility and price declines have made bone graft substitute products an attractive option. Surgeons and patients alike have become increasingly interested in minimally invasive procedures, which greatly decrease the pain associated with bone graft procedures.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for:
The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantation (ACI). As the market continued to recover from the economic crisis, slow growth was often seen across different regions. The ACI market underwent drastic changes in 2012 due to modifications in the European Medicines Agency (EMA) regulations.
While autografts were still commonly used in 2012, easy accessibility and price declines have made bone graft substitute products an attractive option. Surgeons and patients alike have become increasingly interested in minimally invasive procedures, which greatly decrease the pain associated with bone graft procedures.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for:
- Austria
- Belgium
- Denmark
- Finland
- France
- Germany
- Italy
- Luxembourg
- Netherlands
- Norway
- Portugal
- Spain
- Sweden
- Switzerland
- U.K.
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment & Country
- Trend Analysis by Segment & Country
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback and Market Monitoring
- Bone Graft Substitute Market
- Allograft Bone Graft Substitute Market
- Synthetic Bone Graft Substitute Market
- Demineralized Bone Matrix Bone Graft Substitute Market
- Hyaluronic Acid Viscosupplementation Market
- Bone Morphogenetic Protein Growth Factor Market
- Autologous Chondrocyte Implantation Market
- Allograft Cervical Spine Market
- Allograft Thoracolumbar Spine Market
- Allograft Trauma and Reconstruction Market
- Allograft Craniomaxillofacial Market
- Synthetic Cervical Spine Market
- Synthetic Thoracolumbar Spine Market
- Synthetic Trauma and Reconstruction Market
- Synthetic Craniomaxillofacial Market
- Cervical Spine Demineralized Bone Matrix Market
- Thoracolumbar Spine Demineralized Bone Matrix Market
- Trauma and Reconstruction Demineralized Bone Matrix Market
- Craniomaxillofacial Demineralized Bone Matrix Market
- DePuy SynthesOlympus
- Zimmer
- Wright Medical
- Smith & Nephew
- RottaPharm
- Fidia
- Genzyme
- Medtronic
- TRB Chemedica
- Laboratoire Genevrier
- Stryker
- RTI Biologics
- Biomet
- Croma-Pharma
- TiGenix
- Fin-Ceramica
- Tedec-Meiji
- Seikagaku
EXECUTIVE SUMMARY
1.1 TOTAL EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET
1.2 BONE GRAFT SUBSTITUTE MARKET
1.3 ALLOGRAFT BONE GRAFT SUBSTITUTE MARKET
1.4 SYNTHETIC BONE GRAFT SUBSTITUTE MARKET
1.5 DEMINERALIZED BONE MATRIX BONE GRAFT SUBSTITUTE MARKET
1.6 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.7 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET
1.8 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
1.9 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET
3.1 INTRODUCTION
3.1.1 Products
3.1.1.1 Growth Factors
3.1.1.2 Bone Graft Substitutes
3.1.1.3 Hyaluronic Acid Viscosupplementation
3.1.1.4 Autologous Chondrocyte Implantation
3.2 CURRENCY EXCHANGE RATE
3.3 MARKET OVERVIEW
3.4 TREND ANALYSIS
3.5 DRIVERS AND LIMITERS
3.5.1 Market Drivers
3.5.2 Market Limiters
3.6 COMPETITIVE ANALYSIS
3.7 MARKET CONCENTRATION
3.8 MERGERS AND ACQUISITIONS
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP per Capita
4.1.3 Procedures
4.1.4 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 SPAIN
4.6 ITALY
4.7 BENELUX
4.8 SCANDINAVIA
4.9 SWITZERLAND
4.10 AUSTRIA
4.11 PORTUGAL
BONE GRAFT SUBSTITUTE MARKET
5.1 INTRODUCTION
5.1.1 Volumes Represented per Procedure
5.2 MARKET OVERVIEW
5.2.1 Bone Graft Substitute Market by Indication
5.2.2 Bone Graft Substitute Market by Segment
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Bone Graft Substitute Market
5.3.2 Total Allograft Market
5.3.2.1 Total Allograft Spine Market
5.3.2.1.1 Allograft Cervical Spine Market
5.3.2.1.2 Allograft Thoracolumbar Spine Market
5.3.2.1.3 Allograft Trauma and Reconstruction Market
5.3.2.2 Allograft Craniomaxillofacial Market
5.3.3 Total Synthetic Market
5.3.3.1 Total Synthetic Spine Market
5.3.3.2 Synthetic Cervical Spine Market
5.3.3.3 Synthetic Thoracolumbar Spine Market
5.3.3.4 Synthetic Trauma and Reconstruction Market
5.3.3.5 Synthetic Craniomaxillofacial Market
5.3.4 Total Demineralized Bone Matrix Market
5.3.4.1 Total Spine Demineralized Bone Matrix Market
5.3.4.2 Cervical Spine Demineralized Bone Matrix Market
5.3.4.3 Thoracolumbar Spine Demineralized Bone Matrix Market
5.3.4.4 Trauma and Reconstruction Demineralized Bone Matrix Market
5.3.4.5 Craniomaxillofacial Demineralized Bone Matrix Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Hyaluronic Acid Viscosupplementation Market
6.3.2 Single-Injection Market
6.3.2.1 Three-Injection Market
6.3.2.2 Five-Injection Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS
BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET
7.1 INTRODUCTION
7.2 MARKET ANALYSIS AND FORECAST
7.3 MARKET DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
7.4 COMPETITIVE ANALYSIS
AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
8.1 INTRODUCTION
8.1.1 Regulations and Legislation
8.2 MARKET ANALYSIS AND FORECAST
8.3 DRIVERS AND LIMITERS
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 COMPETITIVE ANALYSIS
ABBREVIATIONS
1.1 TOTAL EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET
1.2 BONE GRAFT SUBSTITUTE MARKET
1.3 ALLOGRAFT BONE GRAFT SUBSTITUTE MARKET
1.4 SYNTHETIC BONE GRAFT SUBSTITUTE MARKET
1.5 DEMINERALIZED BONE MATRIX BONE GRAFT SUBSTITUTE MARKET
1.6 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.7 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET
1.8 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
1.9 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET
3.1 INTRODUCTION
3.1.1 Products
3.1.1.1 Growth Factors
3.1.1.2 Bone Graft Substitutes
3.1.1.3 Hyaluronic Acid Viscosupplementation
3.1.1.4 Autologous Chondrocyte Implantation
3.2 CURRENCY EXCHANGE RATE
3.3 MARKET OVERVIEW
3.4 TREND ANALYSIS
3.5 DRIVERS AND LIMITERS
3.5.1 Market Drivers
3.5.2 Market Limiters
3.6 COMPETITIVE ANALYSIS
3.7 MARKET CONCENTRATION
3.8 MERGERS AND ACQUISITIONS
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP per Capita
4.1.3 Procedures
4.1.4 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 SPAIN
4.6 ITALY
4.7 BENELUX
4.8 SCANDINAVIA
4.9 SWITZERLAND
4.10 AUSTRIA
4.11 PORTUGAL
BONE GRAFT SUBSTITUTE MARKET
5.1 INTRODUCTION
5.1.1 Volumes Represented per Procedure
5.2 MARKET OVERVIEW
5.2.1 Bone Graft Substitute Market by Indication
5.2.2 Bone Graft Substitute Market by Segment
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Bone Graft Substitute Market
5.3.2 Total Allograft Market
5.3.2.1 Total Allograft Spine Market
5.3.2.1.1 Allograft Cervical Spine Market
5.3.2.1.2 Allograft Thoracolumbar Spine Market
5.3.2.1.3 Allograft Trauma and Reconstruction Market
5.3.2.2 Allograft Craniomaxillofacial Market
5.3.3 Total Synthetic Market
5.3.3.1 Total Synthetic Spine Market
5.3.3.2 Synthetic Cervical Spine Market
5.3.3.3 Synthetic Thoracolumbar Spine Market
5.3.3.4 Synthetic Trauma and Reconstruction Market
5.3.3.5 Synthetic Craniomaxillofacial Market
5.3.4 Total Demineralized Bone Matrix Market
5.3.4.1 Total Spine Demineralized Bone Matrix Market
5.3.4.2 Cervical Spine Demineralized Bone Matrix Market
5.3.4.3 Thoracolumbar Spine Demineralized Bone Matrix Market
5.3.4.4 Trauma and Reconstruction Demineralized Bone Matrix Market
5.3.4.5 Craniomaxillofacial Demineralized Bone Matrix Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Hyaluronic Acid Viscosupplementation Market
6.3.2 Single-Injection Market
6.3.2.1 Three-Injection Market
6.3.2.2 Five-Injection Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS
BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET
7.1 INTRODUCTION
7.2 MARKET ANALYSIS AND FORECAST
7.3 MARKET DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
7.4 COMPETITIVE ANALYSIS
AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
8.1 INTRODUCTION
8.1.1 Regulations and Legislation
8.2 MARKET ANALYSIS AND FORECAST
8.3 DRIVERS AND LIMITERS
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 COMPETITIVE ANALYSIS
ABBREVIATIONS